<DOC>
	<DOCNO>NCT02601690</DOCNO>
	<brief_summary>This research study intend look response specific type allergy cell blood ( call T cell ) type immunotherapy product know SPIREs ( Synthetic Peptide Immuno-Regulatory Epitopes ) , across broad range subject . This non-interventional study investigational product administer subject .</brief_summary>
	<brief_title>Observational Analysis T Cell Responses SPIREs Multiple Allergens Subjects With Allergy North America</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>1 . Male female , age 1865 year . 2 . Willing able provide write informed consent . 3 . One year history allergic rhinoconjunctivitis one cat , short ragweed , Rye grass , HDM . 4 . Positive skin prick test allergen subject qualify clinical history . 1 . Clinically relevant history alcohol drug abuse . 2 . Use oral parenteral ( except low dose inhale ) corticosteroid within 2 month prior visit immunosuppressive therapy within 3 month prior visit . 3 . Vaccination/ inoculation within 6 week prior first visit . 4 . A history significant disease disorder ( e.g . autoimmune , cardiovascular , pulmonary , gastrointestinal , liver , renal , neurological , musculoskeletal , endocrine , metabolic , neoplastic/malignant , psychiatric , major physical impairment , severe atopic dermatitis ) . 5 . Subjects take investigational drug within 6 week prior visit currently participate clinical study . 6 . Recent blood donation amount &gt; 100 mL . 7 . Immunotherapy within last 5 year allergens subject would otherwise eligible basis clinical history skin prick test result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Rye Grass</keyword>
	<keyword>Ragweed</keyword>
	<keyword>Cat</keyword>
	<keyword>House Dust Mite</keyword>
</DOC>